Jason Coloma
Chief Executive Officer at Maze Therapeutics
About
Before joining Maze in 2019, he was a venture partner at Third Rock Ventures and spent nearly a decade at Roche, rising to vice president, following earlier bench work as a scientist at Cytokinetics. He also lectures and advises students at Stanford University and USC's Mann Division of Healthcare and Biopharmaceutical Business.
Chief Executive Officer at Maze Therapeutics
Intro paths
→
In turn, Jason can intro founders to Maze Therapeutics's investors below.
Maze Therapeutics's investors · 7
Andreessen HorowitzMenlo Park · $500K – $50M checksARCH Venture PartnersChicago · $50K – $250M checksForesite CapitalWest HollywoodFrazier Life SciencesPalo Alto · since 2025GV (Google Ventures)Mountain View · $250K – $50M checksJanus Henderson InvestorsLondon · since 2025Venrock Healthcare Capital PartnersNew York · since 2025
Frequently asked questions
- Who is Jason Coloma?
- Before joining Maze in 2019, he was a venture partner at Third Rock Ventures and spent nearly a decade at Roche, rising to vice president, following earlier bench work as a scientist at Cytokinetics. He also lectures and advises students at Stanford University and USC's Mann Division of Healthcare and Biopharmaceutical Business.
- Where does Jason Coloma work?
- Jason Coloma is Chief Executive Officer at Maze Therapeutics.